Evidence map›Paper›PMID 39853217›Full record

Observational studyNursing research

Lessons Learned in Virtual Launch of an Antenatal Opioid Exposure Study During the COVID-19 Pandemic.

Jamie E Newman, Megan Dhawan, Leslie Clarke, Sharon Owen, Traci Beiersdorfer, Lindsay M Parlberg, Stephanie L Merhar, Sara B DeMauro, Scott A Lorch, Deanne Wilson-Costello and 7 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Nursing research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Funding

UAB Outcomes of Babies with Opioid Exposure (OBOE study)PL1HD101059 · NICHD · RESEARCH TRIANGLE INSTITUTE · PI BANN, CARLA M · 2019 to 2021
$14.4M
HEAL Initiative: Antenatal Opioid Exposure Longitudinal Study ConsortiumU24HD101059 · NICHD · RESEARCH TRIANGLE INSTITUTE · PI CARLA M BANN, Jamie Elizabeth Newman · 2024 to 2026
$2.3M
UAB Clinical Site HEAL Neonatal Opioid Withdrawal Pharmacological TreatmentsUG1HD107580 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AMBALAVANAN, NAMASIVAYAM · 2021 to 2025
$1.1M
UAB Outcomes of Babies with Opioid Exposure (OBOE study)UG1HD104251 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Namasivayam Ambalavanan, Ada Myriam Peralta-Carcelen · 2024 to 2026
$388k
UAB Outcomes of Babies with Opioid Exposure (OBOE study)RL1HD104251 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AMBALAVANAN, NAMASIVAYAM · 2020 to 2020
$0k
HEAL Initiative: Antenatal Opioid Exposure Longitudinal Study ConsortiumRL1HD104252 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI DEMAURO, SARA BONAMO · 2020 to 2020
$0k
NICHD NIH HHS PL1 HD101059NICHD NIH HHS RL1 HD104251NICHD NIH HHS RL1 HD104252NICHD NIH HHS U24 HD101059NICHD NIH HHS UG1 HD104251NICHD NIH HHS UG1 HD107580
6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic prompted researchers to develop new ways to design and launch studies and recruit and retain participants. Pregnant women and infants are considered vulnerable populations in research, and families affected by substance use are particularly difficult to recruit and retain. Recruitment for studies involving medical technologies such as MRI can also be difficult due to misconceptions and fear of the technologies.

objectivesThis article aims to describe "lessons learned" during the launch of the Outcomes of Babies with Opioid Exposure (OBOE) study, including successes and challenges when working with high-risk infants and families and the importance of engaging participants through recruitment materials and retention efforts.

methodsThe OBOE study is a multisite prospective longitudinal cohort study comparing infants with antenatal opioid exposure to unexposed controls from birth to 2 years of age. Chi-square tests were used to examine refusal reasons among caregivers of eligible infants by exposure group and differences in 6-month retention among subgroups based on social determinants of health.

resultsFour factors were essential in establishing the consortium, implementing the study, and retaining participants: (a) creating venues for collaboration, (b) pivoting from in-person to virtual training, (c) anticipating potential enrollment barriers and addressing them directly, and (d) engaging participants through recruitment materials and retention efforts. With these factors in place, only 5% of caregivers of eligible opioid-exposed infants and 8% of control infants declined to participate in the study because of MRIs. Of 310 enrolled infants, 234 infants had attended the 6-month visit. Subgroups of enrolled infants were similar in retention at 6 months. DISCUSSION: Reporting our successes and challenges in setting up a nationwide consortium during the pandemic may help other consortia that need to be set up virtually. We anticipated that the serial MRIs would be a barrier to participation; however, few indicated they refused to participate because of MRIs, suggesting that our efforts to address this potential barrier to enrollment were successful.

Indexed as

Analgesics, OpioidCOVID-19Opioid-Related DisordersPatient SelectionPrenatal Exposure Delayed EffectsAdultFemaleHumansInfantInfant, NewbornLongitudinal StudiesPandemicsPregnancyProspective StudiesSARS-CoV-2Analgesics, OpioidCOVID-19longitudinal studyopioid crisisrecruiting

Identifiers

PMID39853217
PMCPMC12040311

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.